U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772999) titled 'Effect of Comic-Based Education on Attitudes Toward Patient Rights' on Aug. 14. Brief Summ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772375) titled '225 IU Versus 300 IU Starting FSH Dose in PPOS for Good-Prognosis Women' on Aug. 13. Brief... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773246) titled 'Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD' on Aug. 14. Brief... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773454) titled 'Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... Read More